Impaired gamma interferon responses against parvovirus B19 by recently infected children

Journal of Virology

Volumn 74, Issue 21, 2000, Pages 9903-9910

  Corcoran, A ^a   Doyle, S ^a   Waldron, D ^a   Nicholson, A ^a   Mahon, B P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; VIRUS VACCINE;

ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; ERYTHEMA INFECTIOSUM; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CAPSID; CHILD; EPITOPES; ERYTHEMA INFECTIOSUM; HUMAN; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; PARVOVIRUS B19, HUMAN; PROTEIN CONFORMATION; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0033771146     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.21.9903-9910.2000     Document Type: Article

References (54)

1. Interleukin 10 is a growth factor for a population of regulatory T cells
2. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines
3. Th1/Th2 cell dichotomy in acquired immunity to Bordetella penussis: Variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T cell subsets as Th1, Th2 or Th0
4. Distribution of virus antibody activity among human IgG subclasses
5. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase polymerase chain reaction based assay
6. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system
7. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins
8. Human parvovirus B19 epidemiology and clinical manifestations
9. Intrauterine parvovirus infection associated with hydrops fetalis
10. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection
11. Follicular dendritic cells (FDC) in retroviral infection: Host/pathogen perspectives
12. Use of parvovirus-like particles for vaccination and induction of multiple immune responses
13. + T cell response to repetitive stimulation with antigen-presenting cells in vitro: Implications in designing antigen-presenting cell-based tumor vaccines
14. Low IgG3 and high IgG4 subclass levels in children with advanced human immunodeficiency virus-type 1 infection and elevated IgE levels
15. Report of a collaborative study to establish the international standard for parvovirus B19 serum lgG
16. IgG response to human parvovirus B19 infection
17. Analysis of the T-cell response to picornaviruses: Identification of T-cell epitopes of poliovirus
18. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities
19. Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination
20. Cellular and humoral immune responses to poliovirus in mice: A role for helper T cells in heterotypic immunity to poliovirus
21. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG
22. Specificity of predominant IgG4 antibodies to adult and microfilarial stages of Brugia malayi
23. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy
24. Immune response to B19 parvovirus and an antibody defect in persistent viral infection
25. Identification of a T cell epitope adjacent to neutralizing antibody site 1 of poliovirus type 1
26. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells
27. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: Implications for long term immunity in children
28. + T-cell clones
29. + Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor
30. Interferon-γ mediated immune effector mechanisms against Bordetelia pertussis
31. Approaches to new vaccines
32. Newborns develop a Th1-type immune response to Mycobacterium boris bacillus Calmette-Guerin vaccination
33. Control of immune pathology by regulatory T cells
34. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
35. B cell responses to a peptide epitope. VIII. Immune complex-mediated regulation of memory B cell generation within germinal centers
36. Filarial antibody responses in Wuchereria bancrofti transmission area are related to parusitological but not clinical status
37. Diminished expression of CD40 ligand by activated neonatal T cells
38. Novel transcription map for the B19 (human) pathogenic parvovirus
39. Parvovirus infections and hypoplastic crises in sickle cell anaemia
40. + T cells: A population of T cells with immune regulatory activities in vitro
41. Human parvovirus associated arthritis: A clinical and laboratory description
42. Distinct Th cell subtypes induced with whole cell and acellular pertussis vaccines in children
43. Immunoglobulins in the prophylaxis of parvovirus B19 infection
44. Parvovirus B19 diagnosis in pregnant women-quantification of IgG antibody levels (I.U./ml) with reference to the international parvovirus B19 standard serum
45. Delayed IgG2 humoral response in infants is not due to intrinsic T or B cell defects
46. Recurrent lymphocytic meningitis associated with hereditary isolated IgG subclass 3 deficiency
47. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19
48. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells
49. Effects of recombinant human gamma interferon on intracellular survival of Bordetella pertussis in human phagocytic cells
50. Lymphoproliferative responses after infection with human parvovirus B19
51. Systemic monocyte and T cell activation in a patient with human parvovirus B19 infection
52. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon?
53. Clinical manifestations of human parvovirus B19 in adults
54. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro